BHI News Section Archives - Page 153 of 1201

ROCKVILLE, Md., May 16, 2022 /PRNewswire/ -- Emmes, a global, full-service clinical research organization (CRO) dedicated to supporting the advancement…

admin

Love0

News

May 16, 2022

The Dutch company MIMETAS expanded its license to the HUB Organoid Technology to include all organs – Drug Discovery & Development

MIMETAS, a global leader in Organ-on-a-Chip models and technology and headquartered in the Netherlands (Europe), announces that it has expanded…

admin

Love0

News

May 13, 2022

IndyGeneUS AI Awarded Grant Funding through QuickFire Challenge

IndyGeneUS plans to use the grant funding from Johnson & Johnson Innovation to Scale Blockchain-secured Genomic Data Marketplace and Proprietary…

admin

Love0

News

May 12, 2022

Another Federal Regional Cluster Funding Opportunity Emerges

By: Brian Darmody, Chief Strategy Officer, AURP: Building Communities of Innovation May 10, 2022 Sometime this September, the US Economic…

admin

Love0

News

May 12, 2022

QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A. | Business Wire

HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has signed agreements…

admin

Love0

BHI News Section

Register for Catalyze Pre-IND Webinar on May 18th @ 12 PM ET

Douglas Falk, CEO & Co-founder of Vita Therapeutics Visits BioTalk

Douglas Falk, CEO & Co-founder of Vita Therapeutics Visits BioTalk

Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages

Emmes Supports Landmark mRNA COVID-19 Vaccine Trial in Sub-Saharan Africa

Sponsored Deloitte: Why now could be a great time to start preparing for an IPO | Crain’s New York Business

The Dutch company MIMETAS expanded its license to the HUB Organoid Technology to include all organs – Drug Discovery & Development

IndyGeneUS AI Awarded Grant Funding through QuickFire Challenge

Another Federal Regional Cluster Funding Opportunity Emerges

QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A. | Business Wire

About BioHealth Innovation

Contact

Connect

BHI News Section

About BioHealth Innovation

Contact

Connect

Search